Amivantamab Plus Lazertinib Vs Osimertinib in First Line, Egfr-Mutant Advanced Nsclc: Patientrelevant Outcomes From Mariposa
| dc.contributor.author | Nguyen, D. | |
| dc.contributor.author | Besse, B. | |
| dc.contributor.author | Cho, B. C. | |
| dc.contributor.author | Lee, S. -H. | |
| dc.contributor.author | Lee, K. H. | |
| dc.contributor.author | Lu, S. | |
| dc.contributor.author | Garcia Campelo, M. R. | |
| dc.date.accessioned | 2025-02-25T19:31:34Z | |
| dc.date.available | 2025-02-25T19:31:34Z | |
| dc.date.issued | 2024 | |
| dc.identifier.issn | 1556-0864 | |
| dc.identifier.issn | 1556-1380 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/5916 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Science inc | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Amivantamab Plus Lazertinib Vs Osimertinib in First Line, Egfr-Mutant Advanced Nsclc: Patientrelevant Outcomes From Mariposa | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.author.wosid | Cheng, Ying/Lsl-5582-2024 | |
| gdc.author.wosid | Felip, Enriqueta/Aag-6316-2019 | |
| gdc.author.wosid | Cho, Byoungchul/Lsl-6088-2024 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::conference output | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | [Nguyen, D.] City Hope Natl Med Ctr, Duarte, CA USA; [Besse, B.] Paris Saclay Univ, Inst Gustave Roussy, Villejuif, France; [Cho, B. C.] Yonsei Univ, Div Med Oncol, Yonsei Canc Ctr, Coll Med, Seoul, South Korea; [Lee, S. -H.] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Lee, K. H.] Chungbuk Natl Univ Hosp, Dept Med, Cheongju, South Korea; [Lu, S.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China; [Cheng, Y.] Jilin Canc Hosp, Changchun, Peoples R China; [Yao, Y.] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China; [Girard, N.] Inst Thorax Curie Montsouris, Paris, France; [Girard, N.] Paris Saclay Univ, UVSQ, Versailles, France; [Lin, C. -C.] Natl Cheng Kung Univ Hosp, Tainan, Taiwan; [Felip, E.] Univ Autonoma Barcelona, Vall dHebron Inst Oncol VIHO, Vall dHebron Barcelona Hosp Campus, Med Oncol Serv, Barcelona, Spain; [Aguilar, A.] Dexeus Univ Hosp Barcelona, Med Oncol Serv, IOR, Barcelona, Spain; [Charoentum, C.] Chiang Mai Univ, Maharaj Nakorn Chiang Mai Hosp, Dept Internal Med, Fac Med, Chiang Mai, Thailand; [Cruz, F. J. S. M.] Ist Brasileiro Controle Canc, Sao Paulo, Brazil; [Majem, M.] Hosp Santa Creu i St Pau, Barcelona, Spain; [Lim, C. S.] Hosp Sultan Ismail, Johor Baharu, Johor, Malaysia; [Akamatsu, H.] Wakayama Med Univ Hosp, Internal Med 3, Wakayama, Japan; [Hayashi, H.] Kindai Univ, Fac Med, Dept Med Oncol, Osaka, Japan; [Yang, J. C. -H.] Natl Taiwan Univ Canc Ctr, Dept Med Oncol, Taipei, Taiwan; [Kowalyszyn, R.] Clin Viedma SA, Viedma, Argentina; [Tiscoski, K.] Santa Casa Misericordia Porto Alegre, Porto Alegre, RS, Brazil; [Franke, F.] Oncosite Ctr Pesquisa Clin, Med Oncol, Ijui, Brazil; [Ponomarenko, D.] Irkutsk State Med Univ, Irkutsk State Med Acad Postgrad Educ, Reg Canc Dispensary, Irkutsk, Russia; [Arslan, C.] Izmir Econ Univ, Sch Med, Med Pk Hosp, Dept Med Oncol, Izmir, Turkiye; [Forster, M.] Univ Coll London Hosp NHS Trust, UCL Canc Inst, London, England; [Urban, D.] Chaim Sheba Med Ctr, Dept Med Oncol, Tel Hashomer, Israel; [Urban, D.] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Misch, D.] Helios Klinikum Emil Behring, Dept Pneumol, Berlin, Germany; [Delmonte, A.] IRCCS Ist Romagnolo Tumori IRST, Meldola, Italy; [Montes, L. V. G.] Mexico Ctr Clin Res, Mexico City, DF, Mexico; [Gadgeel, S. M.] Henry Ford Hlth, Henry Ford Canc Inst, Dept Internal Med, Div Hematol & Oncol, Detroit, MI USA; [Cruz-Correa, M.] Pan Amer Ctr Oncol Trials LLC, San Juan, PR USA; [Peguero, J.] Oncol Consultants, Dept Res, Houston, TX USA; [Rousey, S.] Minnesota Oncol Hematol PA, Minneapolis, MN USA; [Gaffar, Y.] Maryland Oncol Hematol PA, Annapolis, MD USA; [Owen, S.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Schuchard, J.] Janssen Global Serv LLC, Horsham, PA USA; [Diels, J.] Janssen Pharmaceut NV, Beerse, Belgium; [Sermon, J.] Janssen Cilag NV, Beerse, Belgium; [Sun, T.; Daksh, M.] Janssen Res & Dev, Raritan, NJ USA; [Ennis, M.; Sethi, S.; Bauml, J. M.] Janssen Res & Dev, Spring House, PA USA; [Fennema, E.] Janssen Res & Dev, San Diego, CA USA; [Garcia Campelo, M. R.] Hosp Univ A Coruna, Med Oncol, Coruna, Spain | en_US |
| gdc.description.endpage | S104 | en_US |
| gdc.description.issue | 10 | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | S103 | en_US |
| gdc.description.volume | 19 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.wos | WOS:001337925600177 | |
| gdc.index.type | WoS | |
| gdc.wos.citedcount | 2 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 |
